Cargando…
Proton Pump Inhibitor Use and Risk of Gastric Cancer: Current Evidence from Epidemiological Studies and Critical Appraisal
SIMPLE SUMMARY: Proton pump inhibitors (PPIs) are prescribed for reducing the amount of stomach acid. PPIs increase the systemic level of gastrin, a trophic hormone, which is reported to be linked with carcinogenesis. Previous epidemiological studies have shown that the use of PPIs increase the risk...
Autores principales: | Poly, Tahmina Nasrin, Lin, Ming-Chin, Syed-Abdul, Shabbir, Huang, Chih-Wei, Yang, Hsuan-Chia, Li, Yu-Chuan (Jack) |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264794/ https://www.ncbi.nlm.nih.gov/pubmed/35804824 http://dx.doi.org/10.3390/cancers14133052 |
Ejemplares similares
-
Deep Learning for the Diagnosis of Esophageal Cancer in Endoscopic Images: A Systematic Review and Meta-Analysis
por: Islam, Md. Mohaimenul, et al.
Publicado: (2022) -
Proton Pump Inhibitors Use and the Risk of Pancreatic Cancer: Evidence from Eleven Epidemiological Studies, Comprising 1.5 Million Individuals
por: Poly, Tahmina Nasrin, et al.
Publicado: (2022) -
A Meta-Analysis of Proton Pump Inhibitor Use and the Risk of Acute Kidney Injury: Geographical Differences and Associated Factors
por: Han, Cheng Ta, et al.
Publicado: (2023) -
Artificial Intelligence in Gastric Cancer: Identifying Gastric Cancer Using Endoscopic Images with Convolutional Neural Network
por: Islam, Md. Mohaimenul, et al.
Publicado: (2021) -
Appropriateness of Overridden Alerts in Computerized Physician Order Entry: Systematic Review
por: Poly, Tahmina Nasrin, et al.
Publicado: (2020)